We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05033860
Recruitment Status : Recruiting
First Posted : September 5, 2021
Last Update Posted : September 5, 2021
Sponsor:
Information provided by (Responsible Party):
Ningbo No. 1 Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by a novel coronavirus, which has developed the global pandemic situation. The promotion of vaccination is an effective strategy to control the epidemic. A total of 19,5738,000 doses of COVID-19 vaccines have been reported in China until August 24th, 2021. During widespread vaccination, the education in COVID-19 prevention and vaccination for residents are also crucial. To figure out the influence of education during waiting time of vaccination, we have designed a randomized controlled trial and planned to distribute leaflets and questionnaires to the residents of Xidian (a town in Ninghai, Zhejiang). This study is of great significance for the prevention of COVID-19 pandemic.

Condition or disease Intervention/treatment Phase
Covid19 Knowledge, Attitudes, Practice Other: Read leaflets containing knowledge of COVID-19 and vaccination. Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 312 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Intervention Model Description:
  1. Intervention group: leaflets containing knowledge of COVID-19 and vaccination were distributed, and questionnaire surveys were conducted afterwards.
  2. Control group: questionnaire surveys were conducted without leaflets distribution.
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents: A Randomized Controlled Trial
Actual Study Start Date : August 18, 2021
Estimated Primary Completion Date : September 20, 2021
Estimated Study Completion Date : September 20, 2021

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Intervention group
Leaflets containing knowledge of COVID-19 and vaccination were distributed, and questionnaire surveys were conducted afterwards.
 Other: Read leaflets containing knowledge of COVID-19 and vaccination.
Leaflets containing knowledge of COVID-19 and vaccination were distributed, and participants are asked to read the leaflets.
No Intervention: Control group
Questionnaire surveys were conducted without leaflets distribution.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Scores of the questionnaire [ Time Frame: 5-20 minutes ]
    All the participants are asked to fulfill a questionnaire entitled "A survey on the public knowledge of COVID-19 and vaccination". The total score of questionnaire is calculated (full mark is 24). A higher score means a better knowledge of COVID-19 and vaccination.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age ≥18;
  2. Residents who are vaccinated with COVID-19 vaccines at Xidian Passenger Station from August 18th to September 20th, 2021;
  3. Able to understand the content of leaflets and questionnaires, and willing to participate in the study.

Exclusion Criteria:

  1. Residents who are unable to get vaccinated with COVID-19 vaccines;
  2. Unable to understand the content of leaflets and questionnaires, or unwilling to participate in the study;
  3. Unreturned or incomplete questionnaires.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05033860


Contacts
Layout table for location contacts
Contact: Lei Xu, MD +86-13486659126 xulei22@163.com
Contact: Siyi Yu +86-18857452628 yusysherry@gmail.com

Locations
Layout table for location information
China, Zhejiang
Ningbo First Hospital Recruiting
Ningbo, Zhejiang, China, 315010
Contact: Lei Xu    13486659126    xulei22@163.com   
Sponsors and Collaborators
Ningbo No. 1 Hospital
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Ningbo No. 1 Hospital
ClinicalTrials.gov Identifier: NCT05033860    
Other Study ID Numbers: 2021-R087
First Posted: September 5, 2021    Key Record Dates
Last Update Posted: September 5, 2021
Last Verified: August 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
 Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases